Logo-bi
Review

1. Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
Sepideh Zununi Vahed, Mohammadreza Ardalan, Nasser Samadi, Yadollah Omidi* ORCID
Bioimpacts. 2015;5(1): 45-54. doi: 10.15171/bi.2015.12
PMCID: PMC4401167     PMID: 25901296     Scopus ID: 84924854767    
Article
PDF
XML
Cited By:
28
11
23
Original Research COVID-19

2. Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Khalil Ansarin ORCID, Ramin Tolouian, Mohammadreza Ardalan* ORCID, Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri ORCID, Kenneth R. Chapman ORCID
Bioimpacts. 2020;10(4): 209-215. doi: 10.34172/bi.2020.27
PMCID: PMC7502909     PMID: 32983936     Scopus ID: 85092050012    
Article
PDF
Full Text
XML
Cited By:
81
58
78
Based on a randomized clinical trial, bromhexine is proposed as a potential therapeutic option in COVID-19. A total of 78 patients with similar demographic and disease characteristics were treated with results showing a significant reduction in ICU admissions.
Original Article

3. Podocyte-specific proteins in urinary extracellular vesicles of patients with IgA nephropathy: Vasorin and ceruloplasmin
Negin Farzamikia ORCID, Seyyedeh Mina Hejazian, Soroush Mostafavi, Behzad Baradaran, Sepideh Zununi Vahed* ORCID, Mohammadreza Ardalan* ORCID
Bioimpacts. 2024;. doi: 10.34172/bi.2023.29981
Article
PDF
XML
Cited By:
0

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge